Braiin Ltd (NASDAQ:BRAI – Get Free Report) saw strong trading volume on Monday. 1,110,289 shares traded hands during trading, an increase of 26% from the average daily volume of 878,638 shares. The stock last traded at $2.5630 and had previously closed at $2.45.
Key Braiin News
Here are the key news stories impacting Braiin this week:
- Neutral Sentiment: Several articles discuss brain research, including Alzheimer’s-related microproteins and brain defenses, and a Stanford project using 7-Tesla MRI. New brain atlas reveals thousands of overlooked microproteins linked to Alzheimer’s disease A Hidden Weakness in the Brain’s Defenses Could Help Explain Alzheimer’s Disease Stanford uses 7-Tesla MRI to build predictive model of human brain in new project
- Neutral Sentiment: Other stories cover potential approaches to brain bleeds, memory, anxiety, sleep, and perimenopausal brain fog. These are general health reports, not announcements involving Braiin. East Anglian Air Ambulance proves rapid pre-hospital blood test can diagnose brain bleeds in minutes Scientists Say These Surprising Meds May Ease Perimenopausal Brain Fog
Analyst Upgrades and Downgrades
Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Braiin in a research note on Monday, August 3rd. One investment analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, Braiin has an average rating of “Hold” and a consensus target price of $10.00.
Check Out Our Latest Analysis on BRAI
Braiin Trading Up 22.8%
The business’s 50 day moving average is $4.80 and its 200 day moving average is $6.41.
About Braiin
Braiin Limited is an Australia-based company focused on agriculture, biosecurity and technology. The company develops and provides products, services and data-driven solutions intended to support agricultural productivity, animal health and environmental management.
Braiin’s activities include agricultural and livestock-related solutions, pest and biosecurity management, and technology designed to help customers monitor operations and improve decision-making. Its offerings are aimed primarily at agricultural, rural and environmental applications.
The company serves customers in Australia and may operate internationally through its technology and agricultural businesses.
Read More
- Five stocks we like better than Braiin
- Can Oil’s Big Rally Deliver Reliable Income? 3 Energy Plays to Watch
- Marriott’s Earnings Beat Shows Why It’s More Than a Bet on Travel Demand
- Franklin Templeton’s New ETFs Turn Stock Dividends Into Bitcoin—What’s the Catch?
- Apple’s Earnings Beat Comes With a Catch for Investors Heading Into the Holidays
Receive News & Ratings for Braiin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Braiin and related companies with MarketBeat.com's FREE daily email newsletter.
